Cargando…
METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway
Gastric cancer (GC) poses a significant threat to human health and remains a prevalent form of cancer. Despite clinical treatments, the prognosis for Gastric cancer patients is still unsatisfactory, largely due to the development of multidrug resistance. Oxaliplatin (OXA), a second-generation platin...
Autores principales: | Wang, Yi, Hong, Zhongshi, Song, Jintian, Zhong, Peilin, Lin, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562647/ https://www.ncbi.nlm.nih.gov/pubmed/37822880 http://dx.doi.org/10.3389/fphar.2023.1257410 |
Ejemplares similares
-
DNA Repair Pathways in Cancer Therapy and Resistance
por: Li, Lan-ya, et al.
Publicado: (2021) -
METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020) -
Supercritical fluid extract of Angelica sinensis promotes the anti-colorectal cancer effect of oxaliplatin
por: Hao, Doudou, et al.
Publicado: (2022) -
The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms
por: Zhang, Yuxiang, et al.
Publicado: (2023) -
Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
por: Du, Yue, et al.
Publicado: (2022)